Non-small cell lung cancer (stage III)
Clinical trials for Non-small cell lung cancer (stage III) explained in plain language.
Never miss a new study
Get alerted when new Non-small cell lung cancer (stage III) trials appear
Sign up with your email to follow new studies for Non-small cell lung cancer (stage III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to keep lung cancer at bay
Disease control Recruiting nowThis study tests whether adding a new drug (BL-B01D1) to the standard pill osimertinib can help people with a certain type of Stage III lung cancer stay cancer-free longer. Participants must have an EGFR gene mutation and have already completed chemotherapy and radiation without …
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can surgery after chemoradiation boost lung cancer control?
Disease control Recruiting nowThis trial explores whether adding surgery after standard chemoradiotherapy, followed by the immunotherapy drug durvalumab, is a safe and feasible option for people with stage III non-small cell lung cancer that was initially not removable by surgery. The study will measure how m…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 4 • Sponsor: Idris Bahce • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New combo aims to make inoperable lung cancer operable
Disease control Recruiting nowThis phase 2 trial tests whether giving chemotherapy plus the immunotherapy drug cemiplimab (Libtayo) before surgery can shrink tumors enough to allow surgical removal in people with stage 3 non-small cell lung cancer that has spread to certain lymph nodes (N3). About 21 particip…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Cancer-Fighting virus plus chemo and immunotherapy takes on lung cancer in new trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after initial treatment. It combines an injected virus (Olvi-Vec) that targets cancer cells, followed by chemotherapy and an immunotherapy drug, and compares it to standard chemotherapy a…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill targets Hard-to-Treat lung cancer in patients who Can't have standard therapy
Disease control Recruiting nowThis phase 2 trial is testing a daily pill called sotorasib (AMG510) in people with stage III lung cancer that has a specific genetic change (KRAS G12C) and cannot be treated with standard chemotherapy plus radiation. The study will enroll about 19 participants to see if the drug…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Breathing new life: exercise program aims to ease shortness of breath in advanced lung cancer
Symptom relief Recruiting nowThis study looks at whether pulmonary rehabilitation—a program of exercise and breathing techniques—can improve breathing, fatigue, and quality of life for people with advanced non-small cell lung cancer. Half of the 85 participants will do an 8-week rehab program, while the othe…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New radiation technique aims to protect heart in thoracic cancer patients
Knowledge-focused Recruiting nowThis study tests whether a newer, MRI-guided radiation method (MRgART) is gentler on the heart than standard radiation (LINAC) for people with lung, esophageal, or other chest cancers. About 60 adults will receive radiation and have their heart function checked via MRI and blood …
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Real-World study tracks immune response in lung cancer patients after standard treatment
Knowledge-focused Recruiting nowThis observational study follows 50 people with stage III non-small cell lung cancer who have already received chemo-radiotherapy and are about to start immunotherapy with durvalumab. Researchers will look at how the immune system responds and whether that relates to survival. Th…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC